Sign In |Help & Support
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)

Novel Cell Therapy

Novel Cell Therapy, Total:64 items.

The international standard classification for "Novel Cell Therapy" includes: Biology. Botany. Zoology , Medical materials , Medical Sciences and health care facilities in general .

The Chinese standard classification for "Novel Cell Therapy" includes: Biological agent and blood products , Extracorporeal circulation, artificial organ and prosthesis device , Medical apparatus and devices in general , Marking, packaing, transport and storage .


Group Standards of the People's Republic of China

  • T/SHSYCXH 7-2022 Test method of human monocyte populations from peripheral blood-Flow cytometry
  • T/SBX 055-2022 Test methods for tumorigenicity of stem cell therapy products
  • T/SDHCST 001-2023 General Principles on the Non-Clinical Studies of the Cell Therapy Medical Products
  • T/SDHCST 004-2023 Animal Species and Model Selection for Non-clinical Studies of the Cell Therapy Medical Products
  • T/CSBT 009-2021 Technical guideline for genotyping of erythrocyte blood group
  • T/CEAC 039-2024 Stem cell identification methods
  • T/CACM 1369-2021 Guidelines for clinical diagnosis and treatment of high altitude polycythemia in Chinese medicine
  • T/CITS 379-2025 Cellular immunophenotyping method based on flow cytometry
  • T/GXDSL 005-2025 Quality Control Standards for Cold Chain Transportation of Cell Therapy Products
  • T/CEAC 069-2024 Cell therapy Leukopak raw material collection and immune cell separation technical requirements
  • T/CEAC 105-2025 TIL Cell Therapy Clinical Application Guidelines
  • T/SHSYCXH 8-2022 Test method of human Natural Killer cells and Natural Killer T cells from peripheral blood-Flow cytometry

Professional Standard - Agriculture

  • 142药典 三部-2015 Monograph II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
  • 149药典 三部-2020 Monograph II Therapeutic Human Granulocyte Macrophage Stimulating Factor for Injection
  • 150药典 三部-2020 Monograph Ⅱ Therapeutic topical human granulocyte macrophage stimulating factor gel
  • 118药典 三部-2010 Chapter II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
  • 农业部1719号公告-1-2012 Live swine fever vaccine (passage cell source) (new veterinary drug registration) (three types)
  • 农业部公告第1793号 New veterinary drug: Recombinant avian influenza virus (H5N1 subtype) inactivated vaccine (cell source, Re-5 strain)

Professional Standard - Education

Professional Standard - Hygiene

  • WS/T 245-2005 Reference method for the enumeration of erythrocytes and leucocytes

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

  • GB/T 39730-2020 General requirements for cell counting—Flow cytometry
  • GB/T 39729-2020 General requirements for measurement of cell purity—Flow cytometry

未注明发布机构

  • NCCLS H7-A3-2000 Procedure for determination of hematocrit by microhematocrit method

Professional Standard - Medicine

  • YY/T 1465.4-2017 Immunogenic evaluation method of medical devices-Part4:Phagocytosis of mouse peritoneal macrophages on chicken erythrocytes- Ex-vivo method
  • YY/T 1500-2016 Pyrogen test for medical devices―Monocyte-activation test―Human whole blood ELISA method
  • YY/T 1465.6-2019 Immunogenic evaluation method of medical devices―Part 6:Determination of animal spleen lymphocyte subsets by flow cytometry
  • YY/T 0606.13-2008 Tissue Engineered Medical Product - Part 13: Standard Test Method for Automated Enumeration of Cell Suspensions

Shanghai Provincial Standard of the People's Republic of China

  • DB31/T 687-2013 Basic requirements for clinical cell therapy platform settings

Hebei Provincial Standard of the People's Republic of China

  • DB13/T 5332-2021 Technical specification for clinical operation of cellular immunotherapy

Professional Standard - Pharmaceutical Packaging

Kingdom of Bahrain Testing and Metrology Directorate

  • BH GSO ASTM F3206:2023 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies

GCC Standardization Organization

  • GSO ASTM F3206:2022 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies

American Society for Testing and Materials (ASTM)

  • ASTM F3206-17 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
  • ASTM F3368-19 Standard Guide for Cell Potency Assays for Cell Therapy and Tissue Engineered Products
  • ASTM D3576-20 Standard Test Method for Cell Size of Rigid Cellular Plastics
  • ASTM F895-25 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
  • ASTM D3576-25 Standard Test Method for Cell Size of Rigid Cellular Plastics
  • ASTM E2526-22 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
  • ASTM F895-84(2001)e1 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
  • ASTM F895-84(2006) Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
  • ASTM D6226-21 Standard Test Method for Open Cell Content of Rigid Cellular Plastics
  • ASTM E2526-08 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells

British Standards Institution (BSI)

  • BS PAS 84:2012 Cell therapy and regenerative medicine. Glossary
  • BS PAS 83:2006 Guidance on codes of practice, standardised methods and regulations for cell-based therapeutics
  • BS EN 30993-5:1994 Biological evaluation of medical devices-Tests for cytotoxicity, in vitro methods
  • BS ISO 20391-1:2018 Biotechnology. Cell counting. General guidance on cell counting methods
  • BS 5736-10:1988 Evaluation of medical devices for biological hazards-Method of test for toxicity to cells in culture of extracts from medical devices

American Water Works Association (AWWA)

  • AWWA WQTC55045 New Rapid Methods to Track Diluted Enterobacteriaceae Cells in Drinking Waters
  • AWWA WQTC56962 Concentration and Detection of Microsporidia Using a Newly-Modified Continuous Flow Centrifuge and Flow Cytometry

Korean Agency for Technology and Standards (KATS)

American National Standards Institute (ANSI)

Bureau of Indian Standards

  • IS 17711-2021 Biotechnology General requirements for transportation of cells for therapeutic use

International Organization for Standardization (ISO)

  • ISO 21973:2020 Biotechnology — General requirements for transportation of cells for therapeutic use

Canadian Standards Association (CSA)

  • CAN/CSA Z900.2.5-2012 Lymphohematopoietic Cells for Transplantation, Includes Update No. 1 (2013), Update No. 2 (2016)

IT-UNI

  • UNI ISO 21973:2021 Biotechnology - General requirements for transportation of cells for therapeutic use

IPC - Association Connecting Electronics Industries

Ente Nazionale Italiano di Unificazione

Gosstandart of Russia

  • GOST R ISO 10993.5-1999 Medical devices. Biological evaluation of medical devices. Part 5. Tests for cytotoxicity: in vitro methods